Skip to main content

CLENZIDERM PORE THERAPY

NDC 62032-612 · Obagi Cosmeceuticals LLC

Generic nameSALICYLIC ACID
Dosage formLIQUID
RouteTOPICAL
Active ingredient(s)SALICYLIC ACID
Strength20 mg/mL
Marketing categoryOTC MONOGRAPH DRUG

Packages

62032-612-04 — 148 mL in 1 BOTTLE, PLASTIC (62032-612-04)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

61328-404 — SALICYLIC ACID, 61589-9801 — Salicylic acid, 61805-117 — SALICYLIC ACID, 61995-0030 — Sulfur, Salicylic Acid, 61995-1606 — Salicylic Acid, 61995-1607 — Salicylic Acid, 61995-2060 — Salicylic Acid, 61995-2753 — Salicylic Acid, 61995-3761 — Salicylic Acid, 62032-610 — SALICYLIC ACID, 62032-617 — Salicylic Acid, 62673-059 — Salicylic Acid, 62673-060 — Salicylic Acid, 62742-4065 — Salicylic Acid, 62742-4069 — Salicylic Acid, 62742-4074 — Salicylic Acid, 62742-4076 — Salicylic Acid, 62742-4107 — Salicylic Acid, 62742-4193 — Salicylic Acid, 62742-4195 — Salicylic Acid, +1442 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels